Versor Investments LP Purchases Shares of 15,200 Bath & Body Works, Inc. $BBWI

Versor Investments LP acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 15,200 shares of the company’s stock, valued at approximately $455,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Stonehage Fleming Financial Services Holdings Ltd acquired a new stake in shares of Bath & Body Works in the second quarter worth $33,000. SVB Wealth LLC acquired a new stake in shares of Bath & Body Works in the first quarter worth $35,000. Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the last quarter. Parallel Advisors LLC grew its stake in shares of Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after acquiring an additional 481 shares during the last quarter. Finally, GKV Capital Management Co. Inc. acquired a new stake in shares of Bath & Body Works in the first quarter worth $69,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $23.63 on Wednesday. Bath & Body Works, Inc. has a 52 week low of $23.40 and a 52 week high of $41.87. The company’s fifty day moving average is $26.72 and its 200-day moving average is $28.92. The company has a market capitalization of $4.87 billion, a PE ratio of 7.01, a P/E/G ratio of 0.86 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter in the previous year, the company earned $0.37 EPS. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were paid a $0.20 dividend. The ex-dividend date was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.4%. Bath & Body Works’s payout ratio is 23.74%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on BBWI shares. Jefferies Financial Group lowered their price objective on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research note on Monday, October 13th. UBS Group lowered their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research note on Friday, August 29th. Citigroup decreased their price target on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research note on Tuesday, August 19th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $26.00 price target on shares of Bath & Body Works in a research note on Monday, October 6th. Finally, Wall Street Zen downgraded shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and an average target price of $36.39.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.